Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
    Bioorg Med Chem. 2010 Mar 1;18(5):1899-909. doi: 10.1016/j.bmc.2010.01.037. Epub 2010 Jan 25.

    Synthesis, metabolism and in vitro cytotoxicity studies on novel lavendamycin antitumor agents.

    Source

    Chemistry Department, Ball State University, Muncie, IN 47306, USA.

    Abstract

    A series of lavendamycin analogues with two, three or four substituents at the C-6, C-7 N, C-2', C-3' and C-11' positions were synthesized via short and efficient methods and evaluated as potential NAD(P)H:quinone oxidoreductase (NQO1)-directed antitumor agents. The compounds were prepared through Pictet-Spengler condensation of the desired 2-formylquinoline-5,8-diones with the required tryptophans followed by further needed transformations. Metabolism and toxicity studies demonstrated that the best substrates for NQO1 were also the most selectively toxic to NQO1-rich tumor cells compared to NQO1-deficient tumor cells.

    Copyright 2010 Elsevier Ltd. All rights reserved.

    PMID:
    20149966
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC2841014
    Free PMC Article

    Images from this publication.See all images (5)Free text

    Scheme 1
    Scheme 3 a
    Scheme 5
    Scheme 2 a
    Scheme 4 a

      Supplemental Content

      Icon for Elsevier Science Icon for PubMed Central

      Save items

      Search details

      See more...

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk